Skip to main content

Peer Review reports

From: Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy

Original Submission
5 Dec 2014 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Resubmission - Version 4
Submitted Manuscript version 4
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Author responded Author comments
Resubmission - Version 6
Submitted Manuscript version 6
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
6 Oct 2015 Editorially accepted
15 Oct 2015 Article published 10.1186/s12885-015-1686-y

You can find further information about peer review here.

Back to article page